Market Place
Sourcing Support
Celularity Appeals Nasdaq Compliance Plan
23 Oct 2024 //
GLOBENEWSWIRE
Celularity Provides Corporate Update
22 Oct 2024 //
GLOBENEWSWIRE
Celularity Inc. Gets Nasdaq Notice; Plans To Appeal.
18 Oct 2024 //
GLOBENEWSWIRE
Celularity Expands Biomaterial Product Portfolio With Rebound
16 Oct 2024 //
GLOBENEWSWIRE
Celularity To Present At H.C. Wainwright Investment Conference
05 Sep 2024 //
GLOBENEWSWIRE
Celularity Appoints Richard J. Berman to its Board of Directors
28 Aug 2024 //
GLOBENEWSWIRE
Celularity Inc. Gets Nasdaq Notice For Late Form 10-Q Filing
23 Aug 2024 //
GLOBENEWSWIRE
Celularity Reports Strong Sales Growth For 2023 And H1 2024
31 Jul 2024 //
GLOBENEWSWIRE
Celularity`s T-Cell Platform Data In Hematologic, Solid Tumors At ASCO
03 Jun 2024 //
GLOBENEWSWIRE
Celularity Nasdaq Late Filing: Form 10-Q Notice Received By Company
24 May 2024 //
GLOBENEWSWIRE
Celularity Placental T Cell Data Shows CAR-T Therapy Benefits
14 May 2024 //
GLOBENEWSWIRE
Celularity Inc. to Host Investor and Analyst Research & Development Day
22 Apr 2024 //
GLOBENEWSWIRE
Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
19 Apr 2024 //
GLOBENEWSWIRE
Celularity Abstract On Placental Biomaterials For Tendons At ORS 2024
18 Apr 2024 //
GLOBENEWSWIRE
Celularity Q1 2024 Sales Ahead, SG&A Cuts, Manufacturing Ramp
15 Apr 2024 //
GLOBENEWSWIRE
Celularity to Present Data Showing Senescent Cell Elimination
08 Apr 2024 //
GLOBENEWSWIRE
Celularity Receives HCPCS Q Code Approval from the U.S. Centers
26 Mar 2024 //
GLOBENEWSWIRE
Celularity Submits Request to U.S. FDA for ODD for PDA-002 Asset FMD
20 Mar 2024 //
GLOBENEWSWIRE
Celularity CEO to Present on Cell Therapy™s Potential
14 Mar 2024 //
GLOBENEWSWIRE
Celularity CEO to Present Keynote Address
12 Mar 2024 //
GLOBENEWSWIRE
Celularity to Present Data Showing Cancer Tumor Reduction by Cell Therapy
07 Mar 2024 //
GLOBENEWSWIRE
Celularity Announces 1-for-10 Reverse Stock Split
23 Feb 2024 //
GLOBENEWSWIRE
Celularity Announces Net Sales Expectations for First Quarter 2024
01 Feb 2024 //
GLOBENEWSWIRE
Celularity and Genting Leaders Comments on Closing $21M Financing Transactions
25 Jan 2024 //
GLOBENEWSWIRE
Celularity Releases CEO Letter to Shareholders
18 Jan 2024 //
GLOBENEWSWIRE
Celularity Confirms Commercialization Agreement with BioCellgraft
04 Jan 2024 //
GLOBENEWSWIRE
Celularity Announces Total Revenue Expectations for Fourth Quarter 2023
03 Jan 2024 //
GLOBENEWSWIRE
Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
24 Nov 2023 //
GLOBENEWSWIRE
Celularity Announces Biomaterial Products Receive SFDA Product Classification
18 Oct 2023 //
GLOBENEWSWIRE
Celularity Appoints Geoffrey Shiu Fei Ling to its Board of Directors
07 Sep 2023 //
GLOBENEWSWIRE
Celularity Inks Research Collaboration with Regeneron
01 Sep 2023 //
CONTRACT PHARMA
Celularity Announces Multi-Y Research Collab Services Agreement With Regeneron
29 Aug 2023 //
GLOBENEWSWIRE
Celularity and Verséa Announce Exclusive U.S. Commercialization Agreement
27 Jul 2023 //
GLOBENEWSWIRE
Celularity Inc. Announces $3 Million Registered Direct Offering
27 Jul 2023 //
GLOBENEWSWIRE
Celularity Announces Presentation at Upcoming 7th International Conference
29 Jun 2023 //
GLOBENEWSWIRE
Celularity Tissue Factor Gene Knockout of Allogeneic Stromal Cells Lowers Thrombotic Effects
01 Jun 2023 //
GLOBENEWSWIRE
Celularity Announces $45 Million Purchase Order
23 May 2023 //
GLOBENEWSWIRE
Celularity Announces Phase 1 Data Showing That MLASC Therapy in Patients
19 May 2023 //
GLOBENEWSWIRE
Celularity Announces Advisory Guidance From Tamer Group Anticipated 2023
10 May 2023 //
GLOBENEWSWIRE
Celularity Announces Acceptance of Presentation at 26th Annual Meeting
01 May 2023 //
GLOBENEWSWIRE
Celularity Announces Clinical Data onHuman Placental-Derived Unmodified Cynk-001
27 Apr 2023 //
GLOBENEWSWIRE
Celularity Inc. Announces $6 Million Registered Direct Offering
05 Apr 2023 //
GLOBENEWSWIRE
Celularity Announces Acceptance of Poster Presentation at 2023 Annual Meeting
04 Apr 2023 //
GLOBENEWSWIRE
Celularity Announces Agreement with AD Ports for Exclusive Product Distribution
28 Mar 2023 //
GLOBENEWSWIRE
Celularity warns of looming layoffs, spotlights early programs as money runs dry
27 Jan 2023 //
ENDPTS
Celularity Completes Strategic Review of 2023 Initiatives
26 Jan 2023 //
GLOBENEWSWIRE
Celularity & CH Group Announce Product Distribution Agreement with Tamer Group
11 Jan 2023 //
PR NEWSWIRE
Celularity and CH Trading Group Announce Territory Distribution Agreement
11 Jan 2023 //
BUSINESSWIRE
Celularitya Placental-Derived Allogeneic Cell Therapy Clinically Meaningful
06 Jan 2023 //
GLOBENEWSWIRE
Celularity Appoints Paul Graves as Chief Communications Officer
04 Jan 2023 //
GLOBENEWSWIRE
Celularity Presents Preclinical Data on CYNK-101, its Allogeneic at (SITC)
10 Nov 2022 //
GLOBENEWSWIRE
Imugene’s onCARlytics combination with Celularity’s placental CYCART-19 T cells
10 Nov 2022 //
GLOBENEWSWIRE
Celularity Promotes Two Executives in Executive Leadership Team
06 Oct 2022 //
GLOBENEWSWIRE
Celularity to Present at Jefferies Cell and Genetic Medicine Summit
27 Sep 2022 //
GLOBENEWSWIRE
Celularity Publishes New Data in Frontiers in Immunology Placental (CYNK)
26 Sep 2022 //
GLOBENEWSWIRE
Celularity Enters Into $150 Million Pre-Paid Advance Agreement with Yorkville
15 Sep 2022 //
GLOBENEWSWIRE
